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hormone level. This paper describes our experience with interstitial implantation of single or multiple point sources of yttrium90 in the treatment of acromegaly. Using an optimal dose of interstitial radiation, we anticipated that there would be a differential effect on the growth hormone producing adenoma of acromegaly with sparing of the normal pituitary remnant. In view of the above data, we decided that no portion of the adenoma should receive less than 9,000 r; no portion of the pituitary remnant, more than 20,000 r; and no significant volume of nervous tissue, more than 6,000 r.
In addition, several cases underwent cryogenic destruction of their gland, for reasons to be described below.
MATERIAL
As listed in Table I , 11 patients with acromegaly with documented intrasellar tumours without suprasellar extension have been treated with stereotactic surgery. Each of these was found to have elevated serum growth hormone levels, not suppressible to zero by an oral glucose load, thus confirming the diagnosis of acromegaly (Earll, Sparks, and Forsham, 1967) . Eight of these cases received implantation of interstitial sources of yttrium90 and three cases underwent central cryogenic destruction of their tumour. Of the eight cases treated with yttrium90, four were males and four females. Their ages ranged from 18 to 56. Of the three patients treated with cryosurgery, two were males, and one was a female. Six of the 11 patients had had one or more courses of previous radiation two and a half to seven and a half years previously. For reasons to be described below, those patients with severe erosion of the floor of the sella were selected for cryogenic surgery. Review of Table I indicates, as might be expected, that those cases with erosion of the floor of the sella were among the larger tumours in the series. There were, however, equally large tumours in the yttrium90 treated group.
Stereotactic treatnment of acromegaly of having no portion of the adenoma receive less than 9,000 r and no portion of the normal pituitary remnant more than 20,000 r, the assumption was made that the pituitary remnant would always be subcapsular in location. Personal experience, at craniotomy, would indicate that the pituitary remnant is usually situated posteriorly and superiorly, and this has been the experience of others (Ray, 1968) . Figure 1 is a semilog. plot of the radiation dose broadside to a 2 x 3 mm yttrium90 rod of 0-21 mc and a similar rod of 1-3 mc-the lowest and highest activities used in this study. Dose is plotted against distance in millimetres. These values were calculated by the method of the Jones Survey (Jones, Mallard, and Elmanharawy, 1963) and the most recent available figures of Elmanharawy (1965) using the figure of 342,000 r/mc (total decay) at 1 mm broadside to the rod. The fall off in radiation dosage is steep, and approximately 3 mm from the surface of the 0-21 mc source and 5 2 mm from the surface from the 1-3 mc source, the radiation dose is approximately 12,000 r. This dose would seem ideal. Again referring to Fig. 1 less than 4,000 r, a level well tolerated by the surrounding structures. Furthermore, thle decrement continues to be rapid, and the total volume of neural tissue receiving t radiation is small. Figure 2 includes AP and lateral radiographs of a sella, 21 x 13 x 17 mm, containing four yttrium90 rods, 0 49 mc each. Above the radiographs is a diagram of the isodose curve in one plane around these rods. The radiation dose in the cross-fire between the rods is exceedingly high. If the rods are placed more than 5 mm apart, however, the effect of one rod system on the region lateral to its neighbour is negligible.
Thus, by appropriate positioning of single or multiple sources of yttrium90 in the sella turcica, a relatively uniform and critical level of radiation source can be administered to the border of the tumour mass without excessive radiation to the pituitary remnant. FuLrthermore, little radiation will be received by a significant volume of neuronal tissue.
In order to space the radiation sources to give a reasonably uniform dose of radiation to the periphery of the tumour, a reliable estimate of the size and shape of the tumour was needed.
PLAIN RADIOGRAPHS Radiographs and laminograms of the sella turcica were obtained and the width, height, and length of the sella were determined as described by DiChiro and Nelson (1962) Hanafee, Rosen, Weidner, and Wilson (1965) , thus demonstrating another structure presumably immediately lateral to the sella contents.
As a first approximation, the width of the floor of the sella was considered as the width of the tumour. In no case was it necessary to revise this estimate by more than 4 mm. In nine cases in which the lateral view of the carotid siphon crossed squarely over the central portion of the sella turcica (Fig. 3) In all cases, yttrium90 sources or the cryogenic probe were introduced via the transnasal route using the Rand-Wells stereotactic apparatus, as previously described (Rand, Dashe, Paglia, Conway, and Solomon, 1964) .
Previous experience (unpublished data) has shown that yttrium90 sources placed freely in tissue will migrate in the direction of gravity. The use of free yttrium90 sources, therefore, would mitigate against careful calculation of tumour size and accurate placement of the sources. The yttrium90 rods were accordingly fixed by a modification of the screw described by Forrest, Blair, Peebles Brown, Stewart, Sandison, Harrington, Valentine, and Carter (1959) .' This is a stainless screw, tipped with a nylon sheath of varying lengths. Yttrium90 rods can be placed within the sheath and plastic blanks placed between the rods for positive fixation and spacing of the radiation sources. At the top of Fig. 4 is photographed a Forrest screw tipped with an 8 mm nylon sheath containing two 3 mm yttrium rods spaced by a 2 mm plastic blank. Beneath this is a second Forrest screw tipped with a 3 mm sheath containing a single yttrium rod. Below these are the disassembled components. In the cases under discussion, a single midline screw was used or two screws, one each side of the midline, containing one or more rods. As listed in Table I , one to four rods were used with a total dose of 0-8 to 2 mc.
In order to place these screws in the sella, guides and screwdrivers designed by Forrest were used.' These are readily adaptable to the Rand-Wells stereotactic guide, by placing a suitable bushing in the probe carrier.
The patients were placed in the stereotactic headrest and, under x-ray control, the screws were fixed in the floor of the sella turcica, with the nylon sheaths extending through the tumour mass. This method of fixation proved adequate in cases in which the sella floor was not severely eroded. In cases in which the floor of the sella turcica was demineralized and thinned, the tumours were treated stereotactically, using a cryoprobe, 4 76 mm in diameter.2 The number of lesions and time of freezing are summarized in Table I . In each case, the freezing temperature was -180°C. One or two centrally placed cryogenic lesions were used. The success of such lesions has been previously published, along with the development and rationale for this technique (Rand et al., 1964) . Lateral to the sella contents is the rapidly flowing blood contained in the cavernous sinus and carotid arteries.
Superiorly, spinal fluid is circulating in the suprachiasmatic and prepontine cysterns. ' tipped by a nylon sheath I cm long and containing two 3 mm yttrium rods spaced by a 2 mm plastic blank, a Forrest screw tipped with a 4 mm sheath containing a 3 mm yttrium rod, a I cm nylon sheath, a 3 mm x 2 mm yttrium rod, a 2 mm x 2 mm plastic blank, and a 2 mm x 2 mm yttrium rod.
were performed under local anaesthesia with the patient awake. Visual fields, visual acuity, and extraocular mo'yements were tested continuously during the active freezing of the probe tip, as previously described (Rand et al., 1964) . Yttrium90 implantations were performed under general anaesthesia. Before introduction of the destructive medium, a biopsy needle was stereotactically introduced into the sella turcica, and a biopsy confirming an edosinophilic adenoma was obtained in each case. Each patient was admitted to the hospital for extensive metabolic and endocrine evaluation before the above procedures, and subsequently, two months postoperatively and then at intervals, usually of six months.
To date, the patients have been followed for from eight months to 24 months since operation. Studies have included:
GONADOTROPINS Two 24-hour urine samples were analysed for gonadotropins by the method of Bradbury, Brown, and Brown (1949) 1 Two 24-hour urine samples were collected for 1 7-ketosteroids (Drekter, Heisler, Scism, Stern, Pearson, and McGavack, 1952) . In females, a vaginal smear was evaluated for oestrogen effect (Young, Bulbrook, and Greenwood, 1957 Christy, Wallace, and Jailer (1955) . Plasma 17-hydroxycorticosteroids were determined before and after stress stimulation with insulin induced hypoglycaemia (Landon, Wynn, and James, 1963 Figure 5 charts the mean fasting resting growth hormone level of each patient, pre-operatively, and periodically post-operatively, for up to 24 months. The total variation is indicated. The eight cases treated with interstitial yttrium90 are arranged in order of increasing dose of radiation at the gland margin, with the exception of the second case. In this case, a single central rod of 1-3 mc was implanted 2 mm higher than desired. Thus, the calculated dose at the superior border of the gland was. 60,000 r whereas the inferior border received but 8,000 r. All cryogenic lesions were made at -180°C. The To the right, the bar labelled 'normal' indicates the average and variation of resting fasting growth hormone as determined in our laboratory on 157 non-acromegalic subjects. These subjects had carcinoma of the breast, carcinoma of the prostate, and lumbar disc disease. Patients with intracranial disease, overt diabetes mellitus, or other known endocrine disorders were excluded. These values are consistent with normal values reported by others (Unger, Eisentraut, Madison, and Siperstein, 1965) . Table I summarizes these same 11 cases, including details of previous conventional radiation, the size of their tumours, and the therapeutic modality employed. The right side of Table I summarizes the pre-operative and post-operative endocrine studies on these patients. The average plasma growth hormone levels in m,ug/ml., as charted in Fig. 5 Of the eight cases undergoing yttrium90 implantation and receiving 9,000 r to 15,000 r to the entire gland margin, all eight had excessively high growth hormone levels pre-operatively and two of these (Case 1 and Case 7) continue to have elevated, although diminished, fasting growth hormone levels. Case 1 received the lowest dose of radiation in the series, 9,000 r to the gland margin. She had a significant drop in growth hormone level from 115 m,ug/ml. to approximately 20 m,ug/ml., over the first eight months, but subsequently has been followed for a total of 24 months post-operatively without further decrease in her growth hormone level. Case 7 received 12,000 r to the tumour margin, a level which has been highly successful in other patients, but, eight months post-operatively, has failed to show complete ablation of excess growth hormone. Pre-operatively, several of the yttrium90 treated group had deficiencies in one or more other pituitary functions. As seen in Table I , there was a progressive improvement in other pituitary functions over a matter of months, up to 18 months. At this time, eight to 24 months post-operatively, all patients have had a return of other pituitary functions to normal with the exception of Case 2 (J.S.) who, presumably due to excessively high placement of the yttrium90 rod, has developed overt diabetes insipidus. Pre-operatively she was unable to concentrate her urine after an overnight fast. Post-operatively she required Pitressin which she continues to take, although the severity of her diabetes insipidus continues to lessen.
Three cases underwent cryogenic therapy. As seen in Table I , all three tumours were of approximately the same volume. Cases 9 and 10 were spherical and Case 11 oval with the greatest diameter corresponding to the width of the sella turcica. For this reason, Case 11 received two cryogenic lesions, centred 4 mm each side of the midline, whereas Cases 9 and 10 were treated with single midline (Kozak et al., 1966) . Since the development of a reliable radioimmunoassay for growth hormone, several authors have investigated the effect of conventional external beam radiation on the plasma growth hormone levels in acromegaly (Beck et al., 1965; Greenwood et al., 1965; Roth et al., 1967) and have failed to demonstrate a consistent or significant drop in the majority of their subjects. Table I lists the previous conventional radiation therapy received by six of the 11 cases under study. They are not distinguished by either lower fasting growth hormone levels or greater susceptibility to subsequent interstitial radiation or cryosurgery. Indeed, the only case that did not respond satisfactorily to the interstitial application of 12,000 r at the gland margin (Case 7) received 4,475 r of external gamma radiation from a cobalt source, two and a half years previously.
Two cases (Case 5 and Case 7) were first seen before their radiation therapy. Fasting resting growth hormone levels were determined at that time. They were subsequently followed serially, at six month intervals, for over two years. There was no drop in growth hormone levels. This has also been our experience in a larger group of cases who have, as yet, not undergone stereotactic treatment.
On occasion, neurovascular damage (Peck and McGovern, 1966; Darmody, Thomas, and Gurdjian, 1967) , sarcomas of the brain (Goldberg, Sheline, and Malamud, 1963; Waltz and Brownell, 1966) , and carcinoma of the perinasal sinuses (Sheline et al., 1961) have resulted from conventional therapy. In general, these cases have had as a single course, or more commonly as multiple courses, more than the recommended dose of radiation, often over a shorter treatment period than is probably optimal in preventing complication. The report of Crompton and Layton (1961) on delayed fatal radionecrosis of the brain, including hypothalamus, in two cases, one receiving 4,500 r over four weeks and the other, 6,250 r over six weeks, reveals the potential although uncommon hazard of this form of therapy. Complications of conventional radiation therapy, although dramatic, must be rare. Nevertheless, we would consider interstitial radiation a superior form of therapy. It is possible to deliver a higher and controlled dose of radiation to the tumour and avoid significant radiation to the surrounding central nervous system. Stereotactic interstitial radiation has been reported by others with variable success. Molinatti, Camanni, Massara, Olivetti, Pizzini, and Giuliani (1962) , using free yttrium90 pellets, reported clinical benefits and improvement in carbohydrate and calcium metabolism in 16 cases, only one of whom required replacement therapy for adrenal insufficiency. Two females had the return of menstruation and one male, return of potency. Growth hormone was not measured. One case had cerebrospinal fluid rhinorrhoea and paresis of the left oculomotor nerve, and one case had a temporary sixth nerve palsy and another transistory hemianopsia. Three cases had persistent polyuria. Total dose of radiation administered was 14 8 to 42 mc, or seven to 100 times the dose received in our series. Hartog, Doyle, Fraser, and Joplin (1965) Rand et al. Bleasel and Lazarus (1965) 
